Back
ESSA Pharma 10K Form
Sell
35
EPIX
ESSA Pharma
Last Price:
$1.61
Seasonality Move:
-8.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-08-08 | 10Q | EPIX/ESSA Pharma Quarterly |
| 2023-05-09 | 10Q | EPIX/ESSA Pharma Quarterly |
| 2023-02-07 | 10Q | EPIX/ESSA Pharma Quarterly |
| 2022-08-04 | 10Q | EPIX/ESSA Pharma Quarterly |
| 2022-05-10 | 10Q | EPIX/ESSA Pharma Quarterly |
| 2022-02-03 | 10Q | EPIX/ESSA Pharma Quarterly |
Receive EPIX News And Ratings
See the #1 stock for the next 7 days that we like better than EPIX
EPIX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-6.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.68 |
| Price / Book: | 0.61 |
Profitability
| EPS (TTM): | -0.69000 |
|---|---|
| Net Income (TTM): | $-31.1M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
ESSA Pharma Earnings Forecast
Key ESSA Pharma Financial Ratios
-
Per Share Earnings over the last 11 years have been positive in 8 years.
ESSA Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EPIX |
| CUSIP: | 29668H |
| Website: | essapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
EPIX Technical Analysis vs Fundamental Analysis
Sell
35
ESSA Pharma (EPIX)
is a Sell
Is ESSA Pharma a Buy or a Sell?
-
ESSA Pharma stock is rated a SellThe current ESSA Pharma [EPIX] share price is $1.63. The Score for EPIX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.